Soledad Gallego Melcon

25PUBLICATIONS
151CO-AUTHORS
Haematological tumoursMolecular targetsRegenerative medicine (incl. stem cells)Predictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Dec 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Juliet C Gray, Rebekah Weston, Cormac Owens

|Jan 27, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.

Leo Mascarenhas, Steven G DuBois, Catherine M Albert

|Jan 08, 2024
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.

Lucas Moreno, Rebekah Weston, Cormac Owens

|Sep 08, 2023
Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee.

Roelof van Ewijk, Cyrano Chatziantoniou, Madeleine Adams

|Mar 29, 2023
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon.

Guillem Pons, Gabriel Gallo-Oller, Natalia Navarro

|Feb 27, 2023
Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study.

Gianni Bisogno, Veronique Minard-Colin, Ilaria Zanetti

Pageof 5

Frequent Collaborators

8 joint publications

Miguel F Segura

8 joint publications

Josep Roma

8 joint publications

Gianni Bisogno

8 joint publications

Veronique Minard-Colin